Cargando…

Airway tapering: an objective image biomarker for bronchiectasis

PURPOSE: To estimate airway tapering in control subjects and to assess the usability of tapering as a bronchiectasis biomarker in paediatric populations. METHODS: Airway tapering values were semi-automatically quantified in 156 children with control CTs collected in the Normal Chest CT Study Group....

Descripción completa

Detalles Bibliográficos
Autores principales: Kuo, Wieying, Perez-Rovira, Adria, Tiddens, Harm, de Bruijne, Marleen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7160094/
https://www.ncbi.nlm.nih.gov/pubmed/32025831
http://dx.doi.org/10.1007/s00330-019-06606-w
_version_ 1783522689344864256
author Kuo, Wieying
Perez-Rovira, Adria
Tiddens, Harm
de Bruijne, Marleen
author_facet Kuo, Wieying
Perez-Rovira, Adria
Tiddens, Harm
de Bruijne, Marleen
author_sort Kuo, Wieying
collection PubMed
description PURPOSE: To estimate airway tapering in control subjects and to assess the usability of tapering as a bronchiectasis biomarker in paediatric populations. METHODS: Airway tapering values were semi-automatically quantified in 156 children with control CTs collected in the Normal Chest CT Study Group. Airway tapering as a biomarker for bronchiectasis was assessed on spirometer-guided inspiratory CTs from 12 patients with bronchiectasis and 12 age- and sex-matched controls. Semi-automatic image analysis software was used to quantify intra-branch tapering (reduction in airway diameter along the branch), inter-branch tapering (reduction in airway diameter before and after bifurcation) and airway-artery ratios on chest CTs. Biomarkers were further stratified in small, medium and large airways based on three equal groups of the accompanying vessel size. RESULTS: Control subjects showed intra-branch tapering of 1% and inter-branch tapering of 24–39%. Subjects with bronchiectasis showed significantly reduced intra-branch of 0.8% and inter-branch tapering of 19–32% and increased airway–artery ratios compared with controls (p < 0.01). Tapering measurements were significantly different between diseased and controls across all airway sizes. Difference in airway–artery ratio was only significant in small airways. CONCLUSION: Paediatric normal values for airway tapering were established in control subjects. Tapering showed to be a promising biomarker for bronchiectasis as subjects with bronchiectasis show significantly less airway tapering across all airway sizes compared with controls. Detecting less tapering in larger airways could potentially lead to earlier diagnosis of bronchiectasis. Additionally, compared with the conventional airway–artery ratio, this novel biomarker has the advantage that it does not require pairing with pulmonary arteries. KEY POINTS: • Tapering is a promising objective image biomarker for bronchiectasis that can be extracted semi-automatically and has good correlation with validated visual scoring methods. • Less airway tapering was observed in patients with bronchiectasis and can be observed sensitively throughout the bronchial tree, even in the more central airways. • Tapering values seemed to be less influenced by variety in scanning protocols and lung volume making it a more robust biomarker for bronchiectasis detection. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00330-019-06606-w) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-7160094
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-71600942020-04-23 Airway tapering: an objective image biomarker for bronchiectasis Kuo, Wieying Perez-Rovira, Adria Tiddens, Harm de Bruijne, Marleen Eur Radiol Chest PURPOSE: To estimate airway tapering in control subjects and to assess the usability of tapering as a bronchiectasis biomarker in paediatric populations. METHODS: Airway tapering values were semi-automatically quantified in 156 children with control CTs collected in the Normal Chest CT Study Group. Airway tapering as a biomarker for bronchiectasis was assessed on spirometer-guided inspiratory CTs from 12 patients with bronchiectasis and 12 age- and sex-matched controls. Semi-automatic image analysis software was used to quantify intra-branch tapering (reduction in airway diameter along the branch), inter-branch tapering (reduction in airway diameter before and after bifurcation) and airway-artery ratios on chest CTs. Biomarkers were further stratified in small, medium and large airways based on three equal groups of the accompanying vessel size. RESULTS: Control subjects showed intra-branch tapering of 1% and inter-branch tapering of 24–39%. Subjects with bronchiectasis showed significantly reduced intra-branch of 0.8% and inter-branch tapering of 19–32% and increased airway–artery ratios compared with controls (p < 0.01). Tapering measurements were significantly different between diseased and controls across all airway sizes. Difference in airway–artery ratio was only significant in small airways. CONCLUSION: Paediatric normal values for airway tapering were established in control subjects. Tapering showed to be a promising biomarker for bronchiectasis as subjects with bronchiectasis show significantly less airway tapering across all airway sizes compared with controls. Detecting less tapering in larger airways could potentially lead to earlier diagnosis of bronchiectasis. Additionally, compared with the conventional airway–artery ratio, this novel biomarker has the advantage that it does not require pairing with pulmonary arteries. KEY POINTS: • Tapering is a promising objective image biomarker for bronchiectasis that can be extracted semi-automatically and has good correlation with validated visual scoring methods. • Less airway tapering was observed in patients with bronchiectasis and can be observed sensitively throughout the bronchial tree, even in the more central airways. • Tapering values seemed to be less influenced by variety in scanning protocols and lung volume making it a more robust biomarker for bronchiectasis detection. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00330-019-06606-w) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2020-02-05 2020 /pmc/articles/PMC7160094/ /pubmed/32025831 http://dx.doi.org/10.1007/s00330-019-06606-w Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Chest
Kuo, Wieying
Perez-Rovira, Adria
Tiddens, Harm
de Bruijne, Marleen
Airway tapering: an objective image biomarker for bronchiectasis
title Airway tapering: an objective image biomarker for bronchiectasis
title_full Airway tapering: an objective image biomarker for bronchiectasis
title_fullStr Airway tapering: an objective image biomarker for bronchiectasis
title_full_unstemmed Airway tapering: an objective image biomarker for bronchiectasis
title_short Airway tapering: an objective image biomarker for bronchiectasis
title_sort airway tapering: an objective image biomarker for bronchiectasis
topic Chest
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7160094/
https://www.ncbi.nlm.nih.gov/pubmed/32025831
http://dx.doi.org/10.1007/s00330-019-06606-w
work_keys_str_mv AT kuowieying airwaytaperinganobjectiveimagebiomarkerforbronchiectasis
AT perezroviraadria airwaytaperinganobjectiveimagebiomarkerforbronchiectasis
AT tiddensharm airwaytaperinganobjectiveimagebiomarkerforbronchiectasis
AT debruijnemarleen airwaytaperinganobjectiveimagebiomarkerforbronchiectasis
AT airwaytaperinganobjectiveimagebiomarkerforbronchiectasis